Your browser is no longer supported. Please, upgrade your browser.
Settings
GLQ Clough Global Equity Fund daily Stock Chart
GLQ [NYSE]
Clough Global Equity Fund
Index- P/E- EPS (ttm)-1.07 Insider Own8.25% Shs Outstand17.64M Perf Week1.92%
Market Cap224.57M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.70%
Income- PEG- EPS next Q- Inst Own26.50% Short Float- Perf Quarter6.26%
Sales5.94M P/S37.82 EPS this Y- Inst Trans-9.91% Short Ratio0.37 Perf Half Y18.31%
Book/sh12.70 P/B1.00 EPS next Y- ROA- Target Price- Perf Year17.33%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range10.16 - 12.93 Perf YTD14.38%
Dividend1.19 P/FCF- EPS past 5Y0.00% ROI- 52W High-1.55% Beta-
Dividend %9.35% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low25.30% ATR0.10
Employees- Current Ratio- Sales Q/Q16.60% Oper. Margin- RSI (14)57.30 Volatility0.60% 0.72%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.45 Prev Close12.71
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume44.70K Price12.73
Recom- SMA200.20% SMA501.64% SMA2009.65% Volume20,264 Change0.16%
May-08-17 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Apr-28-17 10:00AM  Clough Global Equity Fund Business Wire
Apr-24-17 06:11PM  Clough Global Closed End Funds Announce Portfolio Manager Departure and Appointment of New Interested Trustee Business Wire
Mar-31-17 10:00AM  Clough Global Equity Fund Business Wire
Feb-28-17 10:00AM  Clough Global Equity Fund Business Wire
Feb-06-17 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Jan-31-17 10:00AM  Clough Global Equity Fund Business Wire
Jan-30-17 02:16PM  Saba Capital Management Invests in Clough Global Equity Fund GuruFocus.com
Jan-25-17 04:43PM  Clough Global Closed End Funds Portfolio Manager Departure Business Wire
Dec-30-16 10:00AM  Clough Global Equity Fund Business Wire
Dec-15-16 01:04PM  CLOUGH GLOBAL EQUITY FUND Financials
Dec-14-16 09:00AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Nov-30-16 10:00AM  Clough Global Equity Fund Business Wire
Nov-07-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Oct-31-16 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-31-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-08-16 09:30AM  Clough Global Equity Fund Announces Fund Distribution Rate Change and Declares Monthly Cash Distribution Business Wire
Jul-29-16 10:00AM  Clough Global Equity Fund Business Wire
Jun-30-16 10:00AM  Clough Global Equity Fund Business Wire
May-31-16 10:00AM  Clough Global Equity Fund Business Wire
May-06-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-29-16 09:30AM  Clough Global Equity Fund Business Wire
Mar-31-16 09:35AM  Clough Global Equity Fund Business Wire
Mar-09-16 09:30AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Feb-29-16 09:35AM  Clough Global Equity Fund Business Wire
Feb-08-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jan-29-16 09:30AM  Clough Global Equity Fund Business Wire
Dec-31-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-30-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Oct-30-15 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-15 09:35AM  Clough Global Equity Fund Business Wire
Aug-31-15 09:30AM  Clough Global Equity Fund Business Wire
Aug-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jul-31-15 09:35AM  Clough Global Equity Fund Business Wire
Jul-29-15 04:00PM  Clough Global Equity Fund Announces Voting Results from 2015 Annual Shareholder Meeting Business Wire
Jul-07-15 05:10PM  Clough Global Equity Fund Announces Annual Shareholder Meeting Business Wire
Jun-30-15 09:35AM  Clough Global Equity Fund Business Wire
May-29-15 09:30AM  Clough Global Equity Fund Business Wire
May-11-15 04:00PM  Clough Global Closed-End Funds Approve Participation Agreement Permitting Increased Share Purchases by RiverNorth Funds Business Wire
May-08-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-30-15 09:30AM  Clough Global Equity Fund Business Wire
Apr-20-15 04:00PM  Clough Global Closed-End Funds Adopt Share Repurchase Programs Business Wire
Mar-31-15 10:00AM  Clough Global Equity Fund Business Wire
Feb-27-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-30-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-05-15 09:30AM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Dec-31-14 09:30AM  Clough Global Equity Fund Business Wire
Dec-11-14 04:15PM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Nov-26-14 10:00AM  Clough Global Equity Fund Business Wire
Oct-31-14 09:30AM  Clough Global Equity Fund Business Wire
Oct-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Sep-30-14 09:30AM  Clough Global Equity Fund Business Wire
Sep-12-14 09:30AM  Clough Global Equity Fund Announces Change to Fiscal Year End Business Wire
Aug-29-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-31-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-15-14 10:05AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLQ, HIO, ISD at TheStreet
Jul-08-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Jun-30-14 09:30AM  Clough Global Equity Fund Business Wire
Jun-13-14 10:00AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GLQ, AIF, TCPC at TheStreet
Jun-01-14 05:49AM  How I Made 7% Retirement Income Investing In CEFs at Seeking Alpha
May-30-14 09:30AM  Clough Global Equity Fund Business Wire
May-13-14 10:05AM  3 Stocks With Upcoming Ex-Dividend Dates: GLQ, BGCP, CNW at TheStreet
Apr-30-14 09:30AM  Clough Global Equity Fund Business Wire
Apr-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Mar-31-14 10:00AM  Clough Global Equity Fund Business Wire
Mar-13-14 10:00AM  Dividend Watch: 3 Stocks Going Ex-Dividend Friday: GLQ, DHY, PHD at TheStreet
Feb-28-14 09:30AM  Clough Global Equity Fund Business Wire
Feb-11-14 10:03AM  Tomorrow's Ex-Dividends To Watch: GLQ, MEN, MYD, BKH, AMP at TheStreet
Jan-31-14 09:00AM  Clough Global Equity Fund Business Wire
Jan-15-14 09:30AM  Clough Global Equity Fund Business Wire
Jan-14-14 10:00AM  Tomorrow's Ex-Dividends To Watch: GLQ, GNT, LDP, PKI, GMCR at TheStreet
Jan-06-14 10:00AM  3 With Upcoming Ex-Dividend Dates: GLQ, BSBR, NTAP at TheStreet
Dec-19-13 02:16PM  Clough Global Equity Fund Declares Final Quarterly Cash Distribution of $0.29 Per Share before Moving to New Monthly Distributions Business Wire
Dec-12-13 06:30AM  Clough Global Equity Fund Announces an Annual Increase in Cash Distribution Per Common Share and Changes Distribution Payments to Monthly Business Wire
Nov-26-13 01:27PM  How I Made 7% Income While Lowering Risk at Seeking Alpha
Oct-31-13 09:45AM  Clough Global Equity Fund Business Wire
Oct-09-13 03:02PM  Clough Global Equity Fund Revises Quarterly Cash Distribution Ex-Date and Record Date Business Wire
Oct-08-13 06:30AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-31-13 09:00AM  Clough Global Equity Fund Business Wire
Jul-25-13 03:59AM  The CEF Firecracker at Seeking Alpha
Jul-24-13 09:28AM  A High Income, Lower Risk CEF Portfolio For Retirees at Seeking Alpha
Jul-09-13 06:01PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-30-13 07:00AM  Clough Global Equity Fund Business Wire
Apr-16-13 10:00AM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Appointment of Vincent W. Versaci to the Board of Trustees Business Wire
Apr-02-13 12:27PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-31-13 05:32PM  Clough Global Equity Fund Business Wire
Jan-08-13 11:47AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Oct-05-12 02:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Sep-28-12 01:32PM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Resignation of Andrew C. Boynton Business Wire
Jul-03-12 09:32AM  A Diversified Approach To International Dividends at Seeking Alpha
Apr-03-12 01:16PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-23-12 07:27AM  Dividend Champs With Yields As High As 11.2% at Seeking Alpha
Jan-10-12 12:41PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-09-12 10:44AM  CEF Weekly Review: Convertibles Shine at Seeking Alpha
Dec-14-11 01:41PM  Clough Capital: 3 Interesting Closed-End Funds Are Quasi Hedge Funds at Seeking Alpha
Oct-28-11 12:00AM  Portfolio Insights by Brett Arends: Turmoil leaves closed-end funds on sale at MarketWatch
Oct-05-11 01:06PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-07-11 03:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Clough Global Equity Fund is a closed ended equity mutual fund launched and managed by Clough Capital Partners, L.P. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental and quantitative analysis with a bottom up stock picking approach to create its portfolio, with focus on factors such as a company's competitive position, quality of company management, quality and visibility of earnings and cash flow, balance sheet strength, and relative valuation. The fund follows a theme-based investment process which involves focusing on such events as industry consolidation, technological change, an emerging shortage of a product or raw material, and changes in government regulations. It benchmarks the performance of its portfolio against the S&P 500 Index. Clough Global Equity Fund was formed on January 25, 2005 and is domiciled in the United States.
SCMP Sucampo Pharmaceuticals, Inc. daily Stock Chart
SCMP [NASD]
Sucampo Pharmaceuticals, Inc.
Index- P/E16.89 EPS (ttm)0.61 Insider Own0.10% Shs Outstand46.03M Perf Week-2.84%
Market Cap471.81M Forward P/E9.18 EPS next Y1.12 Insider Trans-88.94% Shs Float26.73M Perf Month1.49%
Income27.20M PEG1.21 EPS next Q0.27 Inst Own58.20% Short Float22.40% Perf Quarter-16.33%
Sales239.10M P/S1.97 EPS this Y-42.20% Inst Trans5.46% Short Ratio8.38 Perf Half Y-34.71%
Book/sh4.01 P/B2.56 EPS next Y7.20% ROA5.50% Target Price18.08 Perf Year-12.77%
Cash/sh- P/C- EPS next 5Y14.00% ROE17.80% 52W Range9.30 - 17.55 Perf YTD-24.35%
Dividend- P/FCF76.10 EPS past 5Y24.80% ROI9.60% 52W High-41.58% Beta1.37
Dividend %- Quick Ratio8.60 Sales past 5Y33.30% Gross Margin70.90% 52W Low10.22% ATR0.34
Employees139 Current Ratio9.30 Sales Q/Q19.30% Oper. Margin21.40% RSI (14)44.17 Volatility2.85% 3.51%
OptionableYes Debt/Eq0.00 EPS Q/Q204.90% Profit Margin11.40% Rel Volume0.46 Prev Close10.50
ShortableYes LT Debt/Eq1.67 EarningsMay 03 BMO Payout0.00% Avg Volume713.91K Price10.25
Recom2.20 SMA20-1.77% SMA50-1.11% SMA200-15.60% Volume326,691 Change-2.38%
Mar-10-17Reiterated WallachBeth Buy $20 → $15
Mar-09-17Reiterated Mizuho Buy $16 → $14
Mar-06-17Reiterated Mizuho Buy $16
Dec-22-16Upgrade Mizuho Neutral → Buy $16
Nov-15-16Reiterated Maxim Group Buy $17 → $19
Nov-14-16Reiterated Mizuho Neutral $13 → $16
Sep-07-16Initiated Northland Capital Outperform
Aug-04-16Downgrade Mizuho Buy → Neutral $13
Aug-01-16Reiterated Maxim Group Buy $26 → $17
May-05-16Upgrade WallachBeth Hold → Buy $16
Apr-20-16Upgrade Mizuho Neutral → Buy $14
Mar-10-16Reiterated WallachBeth Hold $27 → $16
Mar-09-16Reiterated Maxim Group Buy $25 → $26
Jan-15-16Reiterated Mizuho Neutral $19 → $14
Nov-20-15Initiated Jefferies Hold $19
Nov-13-15Reiterated Mizuho Neutral $22 → $19
Oct-29-15Resumed ROTH Capital Buy $29
Oct-09-15Initiated Mizuho Neutral
Sep-03-15Initiated Leerink Partners Mkt Perform
Aug-27-15Reiterated WallachBeth Hold $24 → $27
May-19-17 05:00PM  Edited Transcript of SCMP earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-15-17 08:30AM  Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors Marketwired
May-12-17 05:14PM  Sucampo Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCMP) : May 12, 2017 Capital Cube
May-11-17 04:05PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2017 Health Care Conference GlobeNewswire
08:26AM  Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US : May 11, 2017 Capital Cube
May-06-17 07:40AM  Edited Transcript of SCMP earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-03-17 07:15AM  Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call Accesswire
06:42AM  Sucampo tops 1Q revenue forecasts Associated Press
06:30AM  Sucampo Reports First Quarter 2017 Financial Results GlobeNewswire
Apr-26-17 04:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference GlobeNewswire
03:35PM  ETFs with exposure to Sucampo Pharmaceuticals, Inc. : April 26, 2017 Capital Cube
Apr-19-17 06:30AM  Sucampo Announces First Quarter 2017 Earnings Call GlobeNewswire
Apr-18-17 06:31AM  New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1 GlobeNewswire
Apr-10-17 04:01AM  Sucampo (SCMP) Down 7.6% Since Earnings Report: Can It Rebound? Zacks -7.44%
Apr-07-17 04:51PM  7 of the Worst-Performing Stocks in Gurus' Portfolios GuruFocus.com
Apr-03-17 10:20AM  Sucampo just bought this local rare disease company for $200M at bizjournals.com
10:20AM  Sucampo just bought this local rare disease company for $200M American City Business Journals
06:57AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisiti
06:30AM  Sucampo Acquires Vtesse Inc. GlobeNewswire
Mar-28-17 04:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference GlobeNewswire
Mar-16-17 05:50PM  Local drug company stocks react to Trump's proposed cuts to NIH, FDA at bizjournals.com
05:50PM  Local drug company stocks react to Trump's proposed cuts to NIH, FDA American City Business Journals
Mar-15-17 05:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
Mar-14-17 01:04PM  SUCAMPO PHARMACEUTICALS, INC. Financials
10:11AM  Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert Zacks
Mar-13-17 08:54AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-09-17 10:54AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube -6.64%
10:54AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
10:53AM  Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed Zacks
Mar-08-17 10:20PM  Edited Transcript of SCMP earnings conference call or presentation 8-Mar-17 1:30pm GMT Thomson Reuters StreetEvents +7.11%
01:21PM  Here's Why Sucampo Pharmaceuticals Rose as Much as 13.3% Today at Motley Fool
10:08AM  Nasdaq Leads On Chips; Dow Dips As Caterpillar Off, Banks Up
09:11AM  Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics
08:30AM  Sucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open
06:48AM  Sucampo tops 4Q revenue forecasts
06:36AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors
06:30AM  Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-23-17 04:02PM  Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call GlobeNewswire
Feb-17-17 05:41PM  Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire
02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb-16-17 04:25PM  Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb-09-17 10:36AM  Glaxo (GSK) Beats on Q4 Earnings, Posts Dismal '17 View
06:30AM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference GlobeNewswire
Feb-07-17 10:56AM  Mallinckrodt (MNK) Tops on Earnings in Transition Quarter
Feb-06-17 08:19AM  Portola, HealthCare Royalty Partners Ink $150 Million Deal
Feb-03-17 08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
Feb-02-17 09:49AM  Novartis (NVS) Votubia Gets EU Approval for Label Expansion
07:21AM  Catabasis Hits 52-Week Low on Poor DMD Drug Study Data
Jan-31-17 10:45AM  Mylan (MYL) Gets Favorable Verdict for Copaxone in the US
Jan-30-17 04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
10:20AM  Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
Jan-27-17 02:42PM  AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
Jan-26-17 03:29PM  Celgene (CELG) Misses on Earnings & Revenues, Keeps View
Jan-23-17 05:26PM  Gilead (GILD) HCV Therapy Application Validated in Europe
05:22PM  Bristol-Myers Settles Litigation with Merck for Keytruda
08:28AM  Prima Biomed Initiates Randomized Study for Breast Cancer
Jan-19-17 09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan-18-17 08:29AM  Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
08:26AM  Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan-17-17 09:30AM  Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals -5.60%
08:28AM  Key FDA Events to Watch Out for in Q1
Jan-16-17 08:16AM  4 Profitable Stocks with Amazingly High Returns
08:09AM  5 Top Ranked Stocks with Upgraded Broker Ratings to Buy Now
Jan-13-17 09:55AM  Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan-12-17 04:19PM  TherapeuticsMD's Rejoice Study Data Published in Journal
08:43AM  Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan-11-17 04:42PM  Valeant Streamlines Portfolio with Skincare Brands Sale
09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining, PennyMac Mortgage Investment Trust and Extended Stay America
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-10-17 06:03PM  5 Underperformers of 2016: Turnaround Story in 2017?
09:30AM  Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
Jan-09-17 08:23AM  Go Driehaus Way: 5 Momentum Picks
07:32AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-06-17 10:18AM  Top Ranked Growth Stocks to Buy for January 6th
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
08:51AM  Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock
Jan-03-17 08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Dec-29-16 09:30AM  Zacks.com featured highlights: Calavo Growers, Cytokinetics, Sucampo Pharmaceuticals, State National and CryoLife
Dec-28-16 07:37AM  5 Profitable Stocks to Buy for Great Returns
Dec-27-16 04:17PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
09:07AM  Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up
07:11AM  4 Top Stocks with Earnings Acceleration to Buy in 2017
Dec-23-16 11:22AM  Trump, Interest Rates And Biotech Investing In 2017 at Forbes
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
Dec-22-16 01:19PM  Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes at Insider Monkey
09:43AM  Sucampo Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCMP) : December 22, 2016
06:14AM  Sucampo Pharma upgraded by Mizuho
Dec-21-16 04:15PM  Stock Indexes Calm; Southwestern Energy Up 6%
07:32AM  Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : December 21, 2016
02:00AM  Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021 GlobeNewswire
Dec-20-16 05:40PM  Why NeoPhotonics, Sucampo Pharmaceuticals, and Worthington Industries Slumped Today at Motley Fool -20.51%
02:50PM  Here's Why Sucampo Pharmaceuticals Is Down Over 20% Today at Motley Fool
01:36PM  Dow Flirts With 20,000 As Caterpillar, Goldman Sachs, Nike Score Gains
Dec-19-16 04:06PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.03%
04:01PM  Sucampo Announces Proposed Convertible Senior Note Offering GlobeNewswire
01:47PM  Big-Cap Tech Names, Biotechs, Oils Lifting Market
08:47AM  Agios Stops Development of PKR Activator AG-519, Stock Falls
Dec-16-16 08:17AM  Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The company's marketed product includes AMITIZA (lubiprostone), a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), opioid-induced constipation (OIC)in patients with chronic non-cancer pain, and chronic constipation; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. Its product candidates in clinical development stage comprise Lubiprostone that is in Phase IV clinical trials for the treatment of irritable bowel syndrome with constipation in adult women; Phase III clinical trials for the treatment of pediatric functional constipation and (IBS-C); and completed Phase III clinical trials for the treatment of (CIC) in adults, IBS-C in adult women, and OIC in patients with chronic non-cancer pain, as well as CPP-1X/sulindac combination product, which has completed Phase III clinical trials for the treatment of familial adenomatous polyposis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Getman Daniel PDirectorNov 29Option Exercise6.803,79925,8333,799Nov 30 04:01 PM
Greenleaf PeterCEONov 29Option Exercise6.7582,459556,59884,972Nov 30 04:01 PM
Greenleaf PeterCEONov 29Sale16.7582,4591,381,1882,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 29Sale16.753,79963,6330Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Option Exercise6.8016,201110,16716,201Nov 30 04:01 PM
Greenleaf PeterCEONov 28Option Exercise6.75117,541793,402120,054Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Option Exercise8.3324,975208,04228,424Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Sale16.7324,975417,8323,449Nov 28 09:30 PM
Greenleaf PeterCEONov 28Sale16.91117,5411,987,6182,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Sale16.8916,201273,6350Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Option Exercise8.3399,025824,878102,474Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Sale15.8899,0251,572,5173,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Option Exercise8.3326,000216,58029,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Sale15.7726,000410,0203,449Nov 28 09:30 PM
Smith Andrew PChief Financial OfficerNov 15Sale15.581,76627,514348Nov 16 04:01 PM
CS Credit Suisse Group AG daily Stock Chart
CS [NYSE]
Credit Suisse Group AG
Index- P/E- EPS (ttm)-0.89 Insider Own3.10% Shs Outstand2.08B Perf Week0.84%
Market Cap30.19B Forward P/E29.19 EPS next Y0.50 Insider Trans0.00% Shs Float1.93B Perf Month-5.73%
Income-1852.60M PEG- EPS next Q- Inst Own3.70% Short Float0.22% Perf Quarter-4.04%
Sales17.18B P/S1.76 EPS this Y23.60% Inst Trans6.78% Short Ratio0.95 Perf Half Y5.00%
Book/sh20.02 P/B0.72 EPS next Y2.06% ROA-0.20% Target Price17.85 Perf Year1.12%
Cash/sh199.63 P/C0.07 EPS next 5Y0.30% ROE-4.20% 52W Range10.01 - 16.17 Perf YTD1.19%
Dividend0.70 P/FCF- EPS past 5Y-24.80% ROI2.90% 52W High-10.45% Beta1.39
Dividend %4.83% Quick Ratio- Sales past 5Y-5.50% Gross Margin- 52W Low44.66% ATR0.27
Employees47170 Current Ratio- Sales Q/Q-11.80% Oper. Margin41.80% RSI (14)43.81 Volatility1.12% 1.15%
OptionableYes Debt/Eq4.49 EPS Q/Q278.90% Profit Margin-10.80% Rel Volume0.87 Prev Close14.33
ShortableYes LT Debt/Eq4.49 EarningsApr 26 BMO Payout- Avg Volume4.54M Price14.48
Recom3.00 SMA20-2.26% SMA50-2.13% SMA2001.18% Volume3,931,444 Change1.05%
Feb-17-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-13-17Downgrade Macquarie Neutral → Underperform
Nov-14-16Upgrade BofA/Merrill Neutral → Buy
Nov-10-16Upgrade Keefe Bruyette Mkt Perform → Outperform
Nov-04-16Downgrade Macquarie Outperform → Neutral
Jun-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-27-16Downgrade JP Morgan Neutral → Underweight
Jun-13-16Downgrade Keefe Bruyette Outperform → Mkt Perform
May-20-16Upgrade BofA/Merrill Underperform → Neutral
Apr-05-16Downgrade Exane BNP Paribas Neutral → Underperform
Feb-23-16Upgrade Macquarie Underperform → Outperform
Feb-16-16Downgrade JP Morgan Overweight → Neutral
Feb-05-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-01-15Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-06-15Downgrade RBC Capital Mkts Outperform → Sector Perform $26
Feb-08-13Reiterated RBC Capital Mkts Outperform $27 → $30
Jan-05-10Initiated Barclays Capital Equal Weight
Nov-02-09Upgrade Citigroup Hold → Buy
Aug-20-09Upgrade FBR Capital Underperform → Mkt Perform
Jul-28-09Downgrade FBR Capital Mkt Perform → Underperform
May-26-17 08:11AM  Ian Bremmer Says Impeachment Likely Soon in Brazil Bloomberg Video
May-25-17 11:46PM  CSMC 2017-FHA1 Trust -- Moody's assigns provisional ratings to Re-Performing RMBS issued by CSMC Trust, Series 2017-FHA1 Moody's
01:05PM  Exploring Analysts Latest Price Recommendations for 3M Market Realist
12:45AM  Credit Suisse's Iqbal Sees Strong U.S. Labor Data Bloomberg Video
May-24-17 07:53AM  Fidelity National to Sell Majority Stake in Capco to CD&R Zacks
07:37AM  Analysts on Iron Ore: How Much More Downside? Market Realist
06:12AM  OPEC Is Powerful, but Can't Control Shale: Jan Stuart Bloomberg Video
May-22-17 05:29AM  Credit Suisse Shareholders OK $4.2 Bln Stock Sale Investopedia
May-19-17 07:08AM  Connors Says 2 and 20 in Hedges Funds Is Changing Bloomberg Video
May-18-17 05:03AM  Credit Suisse on track to achieve end-2018 cost target: chairman Reuters
May-15-17 07:44PM  /C O R R E C T I O N -- Credit Suisse AG/ PR Newswire
May-11-17 02:46PM  ClassPass CEO: No plans for an IPO, but it's on our radar CNBC Videos
02:22PM  Expert: Tough to manage one individual quarter for Snap CNBC Videos
May-10-17 07:07PM  Mortgage Repurchase Agreement Financing Trust 2017-1 -- Moody's assigns definitive ratings to structured notes issued by Mortgage Repurchase Agreement Financing Trust, Series 2017-1 Moody's
12:41PM  Tender Option Bond Trust (Credit Suisse Liq.), Floater Certificates, Series 2017-XM0506 -- Moody's Assigns A2/VMIG 1 to Tender Option Bond Trust Floater Certificates, Series 2017-XM0506 Moody's
09:50AM  Commodities Declined on Weakening Fundamentals PR Newswire
09:30AM  Credit Suisse Taps Deutsche Bank's McGuire Amid Equities Revamp Bloomberg
09:03AM  Credit Suisse Plans to Expand in North Carolina to Cut Costs Zacks
May-09-17 02:26PM  Credit Suisse to add 1,200 jobs in Raleigh, North Carolina Reuters
02:24PM  The Latest: NC's LGBT law stalled 1,200 Credit Suisse jobs Associated Press
02:12PM  Credit Suisse Adding Jobs in North Carolina as It Gets Tax Break Bloomberg
11:40AM  Mortgage Repurchase Agreement Financing Trust 2017-1 -- Moody's assigns provisional ratings to structured notes issued by Mortgage Repurchase Agreement Financing Trust, Series 2017-1 Moody's
May-08-17 11:40PM  Credit Suisse to Cut Up to 35 Asia Equities Jobs by June Bloomberg -6.09%
03:15AM  Apple iPad Suppliers to Disappoint in 2Q Barrons.com
May-06-17 10:25AM  10 Funds Yielding Up To 17% That Will Eat You Alive Forbes
May-05-17 04:06PM  Toronto Airport Said Worth $3.7 Billion in Possible Sale Bloomberg
04:00PM  ETFs with exposure to Credit Suisse Group AG : May 5, 2017 Capital Cube
May-04-17 10:42AM  Credit Suisse Group AG :CS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
09:09AM  Credit Suisse Settles Toxic Mortgage Lawsuit for $400 Million TheStreet.com
08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
May-03-17 03:16PM  Credit Suisse pays $400 million over toxic mortgages, failed U.S. credit unions Reuters
03:04PM  Credit Suisse pays $400 mln over toxic mortgages, failed U.S. credit unions Reuters
08:15AM  Post Earnings Coverage as Credit Suisse Q1 Top-line Surged 19% Accesswire
May-02-17 09:15PM  Fed to hike rates in June: Credit Suisse CNBC Videos
May-01-17 07:43PM  Credit Suisse has deployed 20 robots within bank, markets CEO says Reuters
05:22PM  Credit Suisse Notes 'Shareholders' Sentiment' Surrounding Executive Compensation TheStreet.com
Apr-28-17 05:24PM  [$$] Week in Review, April 29 Financial Times
03:27PM  The World's Most Important Financier Bet On MENA Startups. Here's What Happened Next. Forbes
12:19PM  [$$] Credit Suisse pay report approved by just 58% of shareholders Financial Times
05:50AM  Credit Suisse's Thiam Wins Backing for Pay Plan After Bonus Cut Bloomberg
Apr-27-17 09:00AM  Latest Results Suggest European Banks Are out of the Doldrums TheStreet.com
Apr-26-17 07:56PM  PRESS DIGEST- Financial Times - April 27 Reuters
01:49PM  Credit Suisse Avoids IPO for Swiss Bank Unit Investopedia
12:11PM  Credit Suisse's First-Quarter Equities Slump Drives Trading Miss Bloomberg
12:07PM  European stocks log fresh 20-month high ahead of Trump tax unveiling MarketWatch
11:51AM  European markets close higher on earnings; Trump tax plan in focus; Kering soars 9% CNBC
11:03AM  O'Neill on the Cultural Divide Between EU and U.S. Banks Bloomberg Video
09:05AM  [$$] Credit Suisse: Napoleonic code Financial Times
08:30AM  Credit Suisse Announces the Launch of a USO Covered Call Exchange Traded Note: the Credit Suisse X-Links Crude Oil Shares Covered Call ETNs PR Newswire
08:05AM  [$$] Credit Suisse's Smarter Plan to Raise Capital The Wall Street Journal
07:52AM  Credit Suisse seeks capital security with $4 billion cash call Reuters
06:18AM  Five Things You Need to Know to Start Your Day Bloomberg
06:14AM  Credit Suisse Plans $4 Billion Capital Increase, Will Keep Domestic Business In-House TheStreet.com
06:06AM  [$$] Credit Suisse to Raise Capital, Ditch Sale of Swiss Unit The Wall Street Journal
05:01AM  Credit Suisse posts 1Q profit Associated Press
03:34AM  Europe Stocks Rise as Kering, Credit Suisse Climb After Earnings Bloomberg
02:54AM  French presidential first vote has made clients more conf... CNBC Videos
02:27AM  European Stocks Set To Extend Gains, Wall Street Earnings Again In Focus TheStreet.com
02:25AM  Credit Suisse to raise $4B in share issue as 1Q reaps profit Associated Press
02:22AM  Credit Suisse's CEO Says 1Q Has Been Really Good Quarter Bloomberg Video
01:47AM  Stifel Nicolaus' Dichtl on Credit Suisse Earnings Bloomberg Video
01:21AM  Always our intention to raise cash in 2017: Credit Suisse... CNBC Videos
01:21AM  2017 first quarter has been good for us: Credit Suisse CE... CNBC Videos
01:13AM  Credit Suisse to Raise 4 Billion Francs in Rights Offering Bloomberg
01:12AM  Credit Suisse Plans $4 Billion Rights Offering, No Swiss IPO Bloomberg
12:28AM  [$$] Credit Suisse Faces Investor Scrutiny With Earnings Report The Wall Street Journal
Apr-25-17 09:26AM  Credit Suisse, Qatar JV Hires New CEO as Asset Growth Slows Bloomberg
07:30AM  Today's Research Reports on Deutsche Bank and Credit Suisse as Banks Surge on French Election Results Accesswire
05:29AM  [$$] Credit Suisse Faces Investor Scrutiny With Earnings Report The Wall Street Journal
05:00AM  Credit Suisse Spends to Boost Booming Energy Team Amid Cutbacks Bloomberg
Apr-24-17 07:00PM  The Bullish Case For Oil Is Fading Fast Oilprice.com
01:13PM  [$$] What Credit Suisse Needs to Get Investors Back on Side The Wall Street Journal
Apr-23-17 12:04PM  [$$] Credit Suisse braced for shareholder revolt over executive pay Financial Times
10:25AM  Credit Suisse to make capital hike decision after AGM: report Reuters
10:08AM  Credit Suisse to make capital hike decision after AGM - report Reuters
Apr-21-17 12:45PM  Top 7 Financial Stocks to Own for 2017 TheStreet.com
Apr-20-17 01:55PM  Today's charts: Wal-Mart, Kroger price wars; Apple shares gain; JPMorgan upgrades Gap; CVS cuts back on candy Yahoo Finance
Apr-19-17 10:17AM  Credit Suisse Has Made a Normal Correction TheStreet.com
09:07AM  Will the Most Unloved Bull Market Go Further? Bloomberg Video
07:38AM  Will the European Central Bank Follow the Fed? Market Realist
05:52AM  U.K. Stocks Win Credit Suisse Upgrade on Cheapness, Pound Limits Bloomberg
Apr-18-17 09:52PM  Energuate Trust -- Moody's assigns Ba2 rating to Energuate's senior unsecured guaranteed notes; outlook Stable Moody's
10:20AM  Commodities Decreased in March due to Supply Expectations PR Newswire
09:55AM  Norway's sovereign fund backs Credit Suisse executive pay Reuters
04:01AM  Credit Suisse Pay Cuts Too Little Too Late, Glass Lewis Says Bloomberg
04:01AM  Credit Suisse Bonus Cuts Win Nod From Norway's Wealth Fund Bloomberg
Apr-17-17 02:22PM  CREDIT SUISSE: Alphabet is our No. 1 internet stock pick Business Insider
06:02AM  [$$] Tax evasion issue continues to haunt Swiss banking Financial Times
Apr-15-17 12:33AM  [$$] Credit Suisse to Cut Executive Bonuses by 40% The Wall Street Journal
Apr-14-17 06:41AM  Credit Suisse Execs Agree to Cut Bonuses by 40% Investopedia
05:50AM  [$$] Credit Suisse to Cut Executive Bonuses by 40% The Wall Street Journal
Apr-13-17 06:31PM  Credit Suisse Leaders Cut Their Bonuses 40% After Backlash Bloomberg
01:42PM  Credit Suisse Group AG -- Moody's assigns Ba2(hyb) rating to Credit Suisse Group AG's CHF 200 million high-trigger AT1 capital securities Moody's
12:10PM  Be Afraid! Volatility & Fear Measures Back to Brexit Levels Investopedia
09:56AM  Credit Suisse has its own 'Fear Barometer,' and it's flashing red Business Insider
03:17AM  Five Charts That Show Fear Is Rearing Its Head in Global Markets Bloomberg
03:17AM  Fear Is Creeping Back Into Markets Bloomberg
Apr-12-17 10:07PM  Credit Suisse Banks on Asia's Entrepreneurs Barrons.com
02:02PM  Fired Banker Sues Credit Suisse After Rogue-Trader Case Collapse Bloomberg
Apr-10-17 07:49PM  Bond Rigging Suit Quotes Cache of Chats to Boost Accusation Bloomberg
Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets segments. The company offers advisory and financial solutions, such as structured advisory, investment advisory, discretionary asset management, mergers and acquisitions transactions, corporate sales and restructurings, divestitures, takeover defense strategies, equity and fixed income sales, trading, debt and equity securities, spin-offs, debt and equity underwritings, private placements, and derivative products, as well as proprietary and third-party products and services. It also provides traditional and structured lending, payment, foreign exchange, capital goods leasing, trade finance, export finance, factoring, ship and aviation finance services; and fund solutions and fund-linked services. In addition, the company offers investment solutions and services to pension funds, governments, foundations and endowments, corporations, and individuals; and global securities sales, trading and execution, prime brokerage, and investment research services. It operates 401 offices and branches. The company offers its products and services to private, corporate, institutional, ultra-high-net-worth and high-net-worth individuals, small and medium-sized enterprises, institutional clients, and financial institutions, as well as affluent and retail clients. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.